Mutual Fund Details

Tata India Pharma & HealthCare Fund Direct-Growth

Name: Tata India Pharma & HealthCare Fund Direct-Growth
Brand: Tata Mutual Fund

Equity Pharma

NAV

₹37.0237

as on 15 Jun 2026, 11:48 PM

₹0.0081(0.02%)

Last Change

Scheme Ratings

rated byValue Research

Pharma

Rankings based on | as on Invalid date

Download the Paytm Money app now!

Invest in Stocks, F&O, Mutual Funds, IPOs, NFOS and Bonds.

Zero brokerage for 30 days
Zero account opening fees
Zero AMC for life

Scan QR code to download the app

Investment Performance

would have given a return of

₹1,10,871

₹1,21,647

₹1,82,810

₹1,91,017

Bank Account

Fixed Deposit

Regular Mutual Fund

This Fund on Paytm Money

This Mutual Fund

₹91,017

Profit (absolute return)

91.02%

in the last

max

+1% Higher Returns

With Direct Plans on Paytm Money

Investment Returns

In the last 1 month

1.53%

In the last 3 months

6.53%

In the last 6 months

3.95%

In the last 1 year

6.32%

In the last 3 years

91.02%

In the last 5 years

97.79%

In the last 10 years

303.86%

Absolute Returns

CAGR

Scheme Riskometer

low

low to moderate

moderate

moderately high

high

very high

Investors understand that their principal will be at very high risk

Scheme Information

Tata India Pharma & HealthCare Fund Direct-Growth

as of 31 May 2026, 05:30 AM

₹1,386.99 Cr

Scheme Asset Size

Fund Type

Open-End

Exit Load

Exit load of 0.25% if redeemed within 30 days.

0.77%

Expense Ratio

Plan

Growth

0.70%

Cash Holding

Benchmark

BSE Healthcare Total Return Index

Scheme Document

View

Benchmark

BSE Healthcare Total Return Index

Exit Load

Exit load of 0.25% if redeemed within 30 days.

Scheme Document

View

Sectors Holding in this Mutual Fund

as on31 May 2026

Sort By

Value

Sector

Healthcare

93.60%

₹1,298.26 Cr

Chemicals

3.95%

₹54.79 Cr

Consumer Staples

1.35%

₹18.72 Cr

Insurance

0.40%

₹5.55 Cr

Others

0.70%

₹9.71 Cr

Sectors Holding in this Mutual Fund

as on31 May 2026

Sort By

Value

Sector

Healthcare

93.60%

₹1,298.26 Cr

Chemicals

3.95%

₹54.79 Cr

Consumer Staples

1.35%

₹18.72 Cr

Insurance

0.40%

₹5.55 Cr

Others

0.70%

₹9.71 Cr

Companies Holding in this Mutual Fund

as on31 May 2026

Sort By

Value

Company

Sun Pharmaceutical Industries Ltd.

9.38%

₹130.10 Cr

Healthcare Global Enterprises Ltd.

5.87%

₹81.42 Cr

Divi's Laboratories Ltd.

5.80%

₹80.45 Cr

Abbott India Ltd.

5.41%

₹75.04 Cr

Cipla Ltd.

5.18%

₹71.85 Cr

Others

68.36%

₹948.14 Cr

View All

Companies Holding in this Mutual Fund

as on31 May 2026

Sort By

Value

Company

Sun Pharmaceutical Industries Ltd.

9.38%

₹130.10 Cr

Healthcare Global Enterprises Ltd.

5.87%

₹81.42 Cr

Divi's Laboratories Ltd.

5.80%

₹80.45 Cr

Abbott India Ltd.

5.41%

₹75.04 Cr

Cipla Ltd.

5.18%

₹71.85 Cr

Others

68.36%

₹948.14 Cr

View All

Funds in this Category

This fund's returns:

22.97%

Return Duration

3 Years

ICICI Prudential Pharma Healthcare And Diagnostics (P.H.D) Fund Direct - Growth

SBI Healthcare Opportunities Fund Direct Plan-Growth

UTI Healthcare Fund Direct-Growth

AboutTata India Pharma & HealthCare Fund Direct-Growth

Tata India Pharma & HealthCare Fund Direct-Growth is aEquity mutual fund scheme fromTata Mutual Fund. This scheme was launched onInvalid date. It has an AUM of ₹1,386.99 Crores and the latest NAV decalared is ₹37.024 as on16 Jun 2026 at4:57 pm.

Tata India Pharma & HealthCare Fund Direct-Growth scheme return performance in last 1 year is 6.32%, in last 3 years is 91.02% and 268.94% since scheme launch. The min. SIP amount to invest in this scheme is ₹100.